Cargando…
Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
Neuropathic pain (NP) originates from an injury or disease of the somatosensory nervous system. This heterogeneous origin and the possible association with other pathologies make the management of NP a real challenge. To date, there are no satisfactory treatments for this type of chronic pain. Even...
Autores principales: | Vincenzi, Martina, Milella, Michele Stanislaw, D’Ottavio, Ginevra, Caprioli, Daniele, Reverte, Ingrid, Maftei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955776/ https://www.ncbi.nlm.nih.gov/pubmed/35330149 http://dx.doi.org/10.3390/life12030398 |
Ejemplares similares
-
Heroin and its metabolites: relevance to heroin use disorder
por: Milella, Michele Stanislaw, et al.
Publicado: (2023) -
Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain
por: Brandolini, Laura, et al.
Publicado: (2019) -
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
por: Zuena, Anna Rita, et al.
Publicado: (2019) -
The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines
por: Boczek, Tomasz, et al.
Publicado: (2021) -
Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain
por: Ramesh, Geeta, et al.
Publicado: (2013)